Machine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation
NCT ID: NCT06704997
Last Updated: 2024-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
10000 participants
OBSERVATIONAL
2024-06-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with tertiary neurological rehabilitation
Patients with confirmed diagnosis of stroke, acquired brain injuries, traumatic brain injuries, brain tumours, central nervous system infections and polytrauma from acute neurological or neurosurgical units in Singapore. The cohort will be selected from the TTSH Rehabilitation Centre (TTSH RC) admissions from year 2016 to the present.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tan Tock Seng Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chua Sui Geok, Karen
Senior Consultant Dr ( MD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Karen Chua, MBBS
Role: PRINCIPAL_INVESTIGATOR
Tan Tock Seng Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tan Tock Seng Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DSRB 2023/00873
Identifier Type: -
Identifier Source: org_study_id